Art. 43 Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 20…

Annual reporting by the sponsor to the Agency

In forcesince 16 Apr 2014cited 2×
1.

Regarding investigational medicinal products other than placebo, the sponsor shall submit annually through the database referred to in Article 40(1) to the Agency a report on the safety of each investigational medicinal product used in a clinical trial for which it is the sponsor.

2.

In the case of a clinical trial involving the use of more than one investigational medicinal product, the sponsor may, if provided for in the protocol, submit a single safety report on all investigational medicinal products used in that clinical trial.

3.

The annual report referred to in paragraph 1 shall only contain aggregate and anonymised data.

4.

The obligation referred to in paragraph 1 starts with the first authorisation of a clinical trial in accordance with this Regulation. It ends with the end of the last clinical trial conducted by the sponsor with the investigational medicinal product.

  • Code de la santé publiquel1128-12Law

    Le non-respect des articles 37, 42, 43 et 93 du règlement européen (UE) n° 536/2014 du Parlement européen du 16 avril 2014 relatif aux essais cliniques de médicaments sur la communication d'informations destinées à être mise à la …

  • Regulation (EU) 2022/207Law

    … което включва няколко изпитвани лекарствени продукта съгласно член 43, параграф 2 от Регламент (ЕС) № 536/2014, този годишен доклад за …